NCT06986213

Brief Summary

Breast cancer is a health problem with increasing prevalence, along with more effective therapeutic responses and less mutilating surgeries. The process of caring for patients crosses different levels: the diagnostic phase, which is mostly outpatient, the surgical treatment phase, which is mostly short-term inpatient, and the medical treatment phase in a day hospital. An integrated and structured care model based on specialized nursing skills can help improve self-care, quality of life and well-being.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Mar 2025Dec 2026

Study Start

First participant enrolled

March 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 22, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

1.8 years

First QC Date

April 16, 2025

Last Update Submit

May 15, 2025

Conditions

Keywords

Breast cancernursing rehabilitation careself-careupper limb

Outcome Measures

Primary Outcomes (1)

  • Recovering mobility in the homolateral upper limb

    The measures used are functional assessment of the upper limb with the Disabilities of the Arm, Shoulder and Hand (DASH-PT) scale: 30-item self-reported questionnaire in which the response options are presented as 5-point Likert scales. Scores range from 0 (no disability) to 100 (most severe disability). Assessment of muscle strength with dynamometry and assessment of amplitude by goniometry.

    Every 3 weeks until the end of chemotherapy treatment. The result of the evaluation is translated into: Kgf (Muscle strength); Degrees (goniometry). Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks

Other Outcomes (2)

  • Upper limb lymphoedema

    Every 3 weeks until the end of chemotherapy treatment. Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks

  • Sleep quality

    At the start of chemotherapy after surgery, until the end of the treatment cycle (approximately 3 months). Time Points: T0-first evaluation appointment (chemotherapy); T1 at Tx-evaluation every 3 weeks

Study Arms (1)

Heart Pillow Group

EXPERIMENTAL
Behavioral: Heart Pillow Intervention

Interventions

Self-Care: Teach techniques to perform diminished or dependent self-care. Demonstrate assistive devices for self-care. Teach and train techniques and the use of assistive devices. Scare Tissue: Perform massage techniques on scar tissue: gliding and friction. Teach and train massage technique.

Heart Pillow Group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer patients undergoing chemotherapy after surgery.

You may not qualify if:

  • Patients with breast cancer who did not undergo surgical treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Évora

Evora, Portugal

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Isabel Bico, PhD

    University of Évora

    PRINCIPAL INVESTIGATOR
  • Paula Sousa, MsC

    ULSAC

    STUDY CHAIR
  • Sofia Braga, MsC

    ULSAC

    STUDY CHAIR
  • Carmelinda Talhinhas

    ULSAC

    STUDY CHAIR
  • José Moreira

    University of Évora

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Participants are assessed using the instruments and techniques already mentioned. The data are analyzed from a clinical perspective to define and validate diagnoses. Validation is carried out by a rehabilitation nursing specialist. The diagnoses are in accordance with the International Classification for Nursing Practice: \- Committed eating self-care. Self-care transfer committed Self-care grooming (toilet) committed Compromised self-care (going to the bathroom, bladder and bowel control) Compromised hygiene self-care Self-care walking (mobility and going up/down stairs), compromised Inadequate scar tissue The intervention is teaching and training with assistive devices for self-care and teaching and training in massage technique. Progress monitoring is carried out every 2 or 3 weeks, coinciding with the chemotherapy treatment plan.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

April 16, 2025

First Posted

May 22, 2025

Study Start

March 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Participants' personal data will not be shared, as recommended by the ethics committee. All data will be anonymized.

Locations